Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arian Laurence

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 13, 2020
Death-associated protein kinase 1 (DAPK1) controls CD8<sup>+</sup> T cell activation, trafficking, and antitumor activityZhengping Wei, Qiuyang Du, Pingfei Li, et al.
Clinical Epigenetics|August 25, 2015
Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approachFei Gao, Huifang Liang, Hanlin Lu, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinomaZe-yang Ding, Guan-nan Jin, Wei Wang, et al.
Journal of Clinical Immunology|January 6, 2025
Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
Nature Immunology|August 15, 2006
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous systemJason S Stumhofer, Arian Laurence, Emma H Wilson, et al.
Ejhaem|July 18, 2022
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case reportStrachan Mackenzie, Manar Shafat, Harriet Roddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
Transcription factor EB coordinates environmental cues to regulate T regulatory cells' mitochondrial fitness and functionMinghui Xia, Cai Zhang, Yufei Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2019
TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1Cai Zhang, Yaqi Duan, Minghui Xia, et al.
Nature Immunology|June 2, 2025
PD-1 receptor deficiency enhances CD30<sup>+</sup> T<sub>reg</sub> cell function in melanomaJing Xuan Lim, Tegan McTaggart, Seol Kyoung Jung, et al.
Immunity|January 17, 2019
Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic PathologyDaniella M Schwartz, Taylor K Farley, Nathan Richoz, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 13, 2020
Death-associated protein kinase 1 (DAPK1) controls CD8<sup>+</sup> T cell activation, trafficking, and antitumor activityZhengping Wei, Qiuyang Du, Pingfei Li, et al.
Clinical Epigenetics|August 25, 2015
Global analysis of DNA methylation in hepatocellular carcinoma by a liquid hybridization capture-based bisulfite sequencing approachFei Gao, Huifang Liang, Hanlin Lu, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinomaZe-yang Ding, Guan-nan Jin, Wei Wang, et al.
Journal of Clinical Immunology|January 6, 2025
Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)Thomas A Fox, Valerie Massey, Charley Lever, et al.
Nature Immunology|August 15, 2006
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous systemJason S Stumhofer, Arian Laurence, Emma H Wilson, et al.
Ejhaem|July 18, 2022
Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case reportStrachan Mackenzie, Manar Shafat, Harriet Roddy, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022
Transcription factor EB coordinates environmental cues to regulate T regulatory cells' mitochondrial fitness and functionMinghui Xia, Cai Zhang, Yufei Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2019
TFEB Mediates Immune Evasion and Resistance to mTOR Inhibition of Renal Cell Carcinoma via Induction of PD-L1Cai Zhang, Yaqi Duan, Minghui Xia, et al.
Nature Immunology|June 2, 2025
PD-1 receptor deficiency enhances CD30<sup>+</sup> T<sub>reg</sub> cell function in melanomaJing Xuan Lim, Tegan McTaggart, Seol Kyoung Jung, et al.
Immunity|January 17, 2019
Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic PathologyDaniella M Schwartz, Taylor K Farley, Nathan Richoz, et al.
Pageof 11